ography (CTA) as the diagnostic tool
of choice. Level of recommendation: Grade 1 (Strong),
Quality of Evidence: B (Moderate).
1.2: In patients who are thought to have RAA and have
increased radiation exposure risks or renal insufÔ¨Åciency,
we recommend non-contrast-enhanced magnetic resonance angiography (MRA) to establish the diagnosis.
Level of recommendation: Grade 1 (Strong), Quality of
Evidence: C (Low).

